Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pre-analytical considerations in quantifying circulating miRNAs that predict end-stage kidney disease in diabetes

ABSTRACT: Pre-analytical considerations in quantifying circulating miRNAs that predict end-stage kidney disease in diabetes

PROVIDER: PRJNA1108332 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Pre-analytical considerations in quantifying circulating miRNAs that predict end-stage kidney disease in diabetes

Project description:Our previous study identified 8 risk and 9 protective plasma miRNAs associated with progression to end-stage kidney disease (ESKD) in diabetes. This study aimed to elucidate pre-analytical factors that influence the quantification of circulating miRNAs. Using the EdgeSeq platform, which quantifies 2,002 miRNAs in plasma, including ESKD-associated miRNAs, we compared miRNA profiles in whole plasma vs. miRNAs profiles in RNA extracted from the same plasma specimens. Less than half of the miRNAs were detected in standard RNA extracted methods from plasma. Detection of individual and concentrations of miRNAs were much lower when RNA extracted from plasma was quantified by RNA sequencing (RNASeq) or RT-qPCR platforms compared to EdgeSeq. Plasma profiles of miRNAs determined by the EdgeSeq platform had excellent reproducibility in assessment, and had no variation with age, sex, HbA1c, BMI, and cryostorage time. The risk ESKD-associated miRNAs were detected and measured accurately only in whole plasma and using the EdgeSeq platform. Protective ESKD-associated miRNAs were detected by all platforms except RT-qPCR, however, correlations among concentrations obtained with different platforms were weak or non-existent. In conclusion, pre-analytical factors have a profound effect on detection and quantification of circulating miRNAs in ESKD in diabetes. Quantification of miRNAs in whole plasma and using the EdgeSeq platform may be the preferable method to study profiles of circulating cell-free miRNAs associated with ESKD, and possibly other diseases.

2024-05-07 | GSE266819 | GEO

Biospecimen Pre-analytical Variables (BPV)

Project description:Biospecimen Pre-analytical Variables (BPV)

| PRJNA376469 | ENA

Biospecimen Pre-analytical Variables (BPV)

Project description:Biospecimen Pre-analytical Variables (BPV)

| PRJNA932917 | ENA

PREDICT 2

Project description:PREDICT 2

| PRJEB75460 | ENA

Computational and Analytical Framework for Small RNA Profiling by High-Throughput Sequencing

Project description:This SuperSeries is composed of the following subset Series: GSE14694: Computational and Analytical Framework for Small RNA Profiling by High-Throughput Sequencing (reproducibility) GSE14695: Computational and Analytical Framework for Small RNA Profiling by High-Throughput Sequencing (standards) Refer to individual Series

2009-06-02 | E-GEOD-14696 | biostudies-arrayexpress

Analysis of gliomas DNA methylation: Assessment of pre-analytical variables

Project description:MeDIP-Seq for assessment of the effect of pre-analytical variables on DNA methylation

2024-10-07 | GSE278575 | GEO

State-Transition Analysis of Time-Sequential Gene Expression Identifies Critical Points That Predict Leukemia Development

Project description:Temporal dynamics of gene expression are informative of changes associated with disease development and evolution. Given the complexity of high-dimensionaltemporal datasets, an analytical framework guided by a robust theory is needed to interpret time-sequential changes and to predict system dynamics. Herein, we use acute myeloid leukemia as a proof-of-principle to model gene expression dynamics in a transcriptome state-space constructed based on time-sequential RNA-sequencing data. We describe the construction of a state-transition model to identify state-transition critical points which accurately predicts leukemia development. We show an analytical approach based on state-transition critical points identifies step-wise transcriptomic perturbations driving leukemia progression. Furthermore, the gene(s) trajectory and geometry of the transcriptome state-space provides biologically-relevant gene expression signals that are not synchronized in time, and allows quantification of gene(s) contribution to leukemia development. Therefore, our state-transition model can synthesize information, identify critical points to guide interpretation of transcriptome trajectories and predict disease development.

2020-04-23 | GSE133642 | GEO

PREDICT 3 UK23ART

Project description:PREDICT 3 UK23ART

| PRJEB75465 | ENA

PREDICT 3 US21

Project description:PREDICT 3 US21

| PRJEB75462 | ENA

PREDICT 3 US22A

Project description:PREDICT 3 US22A

| PRJEB75463 | ENA